Solution state characterization of amyloid β-derived diffusible ligands

Biochemistry

Volumn 45, Issue 51, 2006, Pages 15157-15167

  Hepler, Robert W ^a   Grimm, Karen M ^a,b   Nahas, Deborah D ^a   Breese, Robert ^a   Dodson, Elizabeth Chen ^a   Acton, Paul ^a   Keller, Paul M ^a   Yeager, Mark ^a   Wang, Hui ^a   Shughrue, Paul ^a   Kinney, Gene ^a   Joyce, Joseph G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Acologix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; ELECTROPHORESIS; IONIC STRENGTH; NITROGEN COMPOUNDS; OLIGOMERS; SIZE EXCLUSION CHROMATOGRAPHY;

AMYLOID Β PEPTIDE; AMYLOID-DERIVED DIFFUSIBLE LIGANDS (ADDL); MONOMERIC PEPTIDES; POLYACRYLAMIDE GEL ELECTROPHORESIS;

AMINO ACIDS;

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; DETERGENT; EXCIPIENT; LIGAND; MONOMER; OLIGOMER;

ALZHEIMER DISEASE; ANALYTIC METHOD; ANIMAL CELL; ATOMIC FORCE MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HIPPOCAMPUS; IN VITRO STUDY; IONIC STRENGTH; LIGHT SCATTERING; MOLECULAR WEIGHT; NERVE DEGENERATION; NONHUMAN; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RAT; REVIEW; STANDARD; TEMPERATURE; ULTRACENTRIFUGATION;

AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, GEL; LIGANDS; MICROSCOPY, ATOMIC FORCE; MOLECULAR WEIGHT; NEURONS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; SOLUTIONS;

EID: 33845935564     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061850f     Document Type: Review

References (49)

1. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun. 120, 885-890.
2. Hardy, J. A., and Higgins, G. A. (1992) Alzheimer's disease: The amyloid cascade hypothesis, Science 256, 184-185.
3. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad Sci. U.S.A. 95, 6448-6453.
4. Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y. S., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., Krafft, G. A., and Klein, W. L. (2004) Synaptic targeting by Alzheimer's-related amyloid β oligomers, J. Neurosci. 24, 10191-10200.
5. Gong, Y. S., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Alzheimer's disease-affected brain: Presence of oligomeric Ab ligands (ADDLs) suggests a molecular basis for reversible memory loss, Proc. Natl. Acad. Sci. U.S.A. 100, 10417-10422.
6. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of Aβ(1-42) into globular neurotoxins, Biochemistry 42 (44), 12749-12760.
7. Klein, W. L., Stine, W. B., and Teplow, D. B. (2004) Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease, Neurobiol. Aging 25, 569-580.
8. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Ab oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
9. Klein, W. L. (2002) ADDLs & protofibrils: The missing links? Neurobiol. Aging 23, 231-233.
10. Whalen, B. M., Selkoe, D. J., and Hartley, D. M. (2005) Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration, Neurobiol. Dis. 20, 254-266.
11. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat. Neurosci. 8(1), 79-84.
12. Rowan, M. J., Klyubin, I., Wang, Q., and Anwyl, R. (2005) Synaptic plasticity disruption by amyloid β protein: Modulation by potential Alzheimer's disease modifying therapies, Biochem. Soc. Trans. 33 (Part 4), 563-567.
13. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416, 535-539.
14. Nomura, I., Kato, N., Kita, T., and Takechi, H. (2005) Mechanism of impairment of long-term potentiation by amyloid β is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons, Neurosci. Lett. 391 (1-2), 1-6.
15. Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El Agnaf, O., Hartley, D. M., and Selkoe, D. J. (2005) Certain inhibitors of synthetic amyloid β-peptide (Ab) fibrillogenesis block oligomerization of natural Ab and thereby rescue long-term potentiation, J. Neurosci. 25, 2455-2462.
16. Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., and Rydel, R. E. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death, J. Neurosci. 25, 1071-1080.
17. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., and Glabe, C. G. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem. 280 (17), 17294-17300.
18. Stine, W. B., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid β peptide oligomerization and fibrillogenesis, J. Biol. Chem. 278, 11612-11622.
19. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases, J. Biol. Chem. 279 (45), 46363-46366.
20. Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., and Klein, W. L. (2001) Vaccination with soluble Ab oligomers generates toxicity-neutralizing antibodies, J. Neurochem. 79, 595-605.
21. Stafford, W. F. (1992) Boundary Analysis in Sedimentation Transport Experiments: A Procedure for Obtaining Sedimentation Coefficient Distributions Using the Time Derivative of the Concentration Profile, Anal. Biochem. 203, 295-301.
22. Philo, J. S. (2000) A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions, Anal. Biochem. 279, 151-163.
23. Stine, W. B., Jr., Snyder, S. W., Ladror, U. S., Wade, W. S., Miller, M. F., Perun, T. J., Holzman, T. F., and Krafft, G. A. (1996) The nanometer-scale structure of amyloid-β visualized by atomic force microscopy, J. Protein Chem. 15, 193-203.
24. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129.
25. Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress, Exp. Neurol. 136, 22-31.
26. Krafft, G. A., Klein, W. L., and Finch, C. E. (2001) Amyloid Beta Protein (Globular assemblies and uses thereof), U.S. Patent 6,218,506.
27. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediates, J. Biol. Chem. 272, 22364-22372.
28. Joyce, J. G., Cook, J. C., Przysiecki, C. T., and Lehman, E. D. (1994) Chromatographic separation of low-molecular-mass recombinant proteins and peptides on Superdex-30 prep grade, J. Chromatogr, Biomed. Appl. 662, 325-334.
29. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory, Nature 440, 352-357.
30. Arimon, M., Diez-Perez, I., Kogan, M. J., Durany, N., Giralt, E., Sanz, F., and Fernandez-Busquets, X. (2005) Fine structure study of Aβ1-42. fibrillogenesis with atomic force microscopy, FASEB J. 19, 1344-1346.
31. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability, J. Biol. Chem. 277, 32046-32053.
32. Huang, T. H., Yang, D. S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., and Chakrabartty, A. (2000) Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide, J. Mol. Biol. 297, 73-87.
33. Kowalewski, T., and Holtzman, D. M. (1999) In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation, Proc. Natl. Acad. Sci. U.S.A. 96, 3688-3693.
34. Wang, Z., Zhou, C., Wang, C., Wan, L., Fang, X., and Bai, C. (2003) AFM and STM study of β-amyloid aggregation on graphite, Ultramicroscopy 97, 73-79.
35. Silva, L. P. (2005) Imaging proteins with atomic force microscopy: An overview, Curr. Protein Pept. Sci. 6, 387-395.
36. Ding, T. T., and Harper, J. D. (1999) Analysis of amyloid-β assemblies using tapping mode atomic force microscopy under ambient conditions, Methods Enzymol. 309, XXXX.
37. Bitan, G., Fradinger, E. A., Spring, S. M., and Teplow, D. B. (2005) Neurotoxic protein oligomers: What you see is not always what you get, Amyloid 12, 88-95.
38. Bitan, G., and Teplow, D. B. (2004) Rapid photochemical cross-linking: A new tool for studies of metastable, amyloidogenic protein assemblies, Acc. Chem. Res. 37 (6), 357-364.
39. Yanagisawa, K. (2004) A pivotal role of gangliosides in the aggregation of amyloid β-protein in the brain, Yakugaku Zasshi 124, 50-52.
40. McLaurin, J., Franklin, T., Fraser, P. E., and Chakrabartty, A. (1998) Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides, J. Biol. Chem. 273, 4506-4515.
41. Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2002) Interactions of amyloid β-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid, Biochemistry 41, 7385-7390.
42. ChooSmith, L. P., GarzonRodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997) Acceleration of amyloid fibril formation by specific binding of Aβ(1-40) peptide to ganglioside-containing membrane vesicles, J. Biol. Chem. 272, 22987-22990.
43. Chauhan, A., Ray, I., and Chauhan, V. P. S. (2000) Interaction of amyloid β-protein with anionic phospholipids: Possible involvement of Lys(28) and C-terminus aliphatic amino acids, Neurochem. Res. 25, 423-429.
44. Ariga, T., and Yu, R. K. (1999) GM1 inhibits amyloid β-protein- induced cytokine release, Neurochem. Res. 24, 219-226.
45. Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., Barlow, E., Ebert, U., and Hillen, H. (2005) Globular amyloid β-peptide oligomer: A homogenous and stable neuropathological protein in Alzheimer's disease, J. Neurochem.
46. Kokubo, H., Kayed, R., Glabe, C. G., and Yamaguchi, H. (2005) Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain, Brain Res. 1031, 222-228.
47. Tang, M. K., and Zhang, J. T. (2001) Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid β-protein in vitro, Acta Pharmacol. Sin. 22, 380-384.
48. Hughes, E., Burke, R. M., and Doig, A. J. (2000) Inhibition of toxicity in the β-amyloid peptide fragment β (25-35) using N-methylated derivatives: A general strategy to prevent amyloid formation, J. Biol. Chem. 275, 25109-25115.
49. Bergamaschini, L., Donarini, C., Rossi, E., De Luigi, A., Vergani, C., and De Simoni, M. G. (2002) Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro, Neurobiol. Aging 23, 531-536.